Cresco Labs

Cresco Labs (CRLBF) stock is currently trading at $0.61 per share on the OTC exchange. This represents a daily decline of -1.61% ($0.0100) from the previous closing price of $0.62. Over the past 52 weeks, CRLBF has traded between a low of $0.59 and a high of $2.30, placing the current price at approximately -73% from its annual high. The stock has a market capitalization of $223.7M, making it a notable cannabis companies tracked by Cannabismarketcap. Cresco Labs operates in the MSO sector, serving the broader cannabis industry.

Cresco Labs (CRLBF) has a current market capitalization of $223.7M, calculated by multiplying its 355.0M shares outstanding by the current stock price of $0.61. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places Cresco Labs among the mid-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $560.5M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.

Cresco Labs (CRLBF) currently reports a gross margin of 49.5%, which means the company retains 49.5 cents of every revenue dollar after direct costs of goods sold. On trailing twelve month revenue of $655.8M, this translates to an estimated gross profit of approximately $324.6M. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of Cresco Labs's financial health.

Cresco Labs (CRLBF) reports trailing twelve month (TTM) revenue of $655.8M, reflecting the total sales generated by the company over the most recent four quarters. Revenue has changed -9.46% year-over-year, reflecting a contraction in top-line performance relative to the prior period. The current price-to-sales ratio is 0.34x, which means investors are paying $0.34 for every $1 of annual revenue — a relatively low valuation in the context of the cannabis sector. Revenue is one of the most closely watched metrics for cannabis companies, as many are still scaling operations in a rapidly evolving regulatory environment. View the full income statement and quarterly revenue breakdown on Cannabismarketcap for detailed trend analysis.

Cresco Labs trades under the ticker symbol CRLBF on the OTC exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts, though some brokers may charge additional fees for OTC-listed securities. The stock sees average daily trading volume of approximately 51.5K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.

Cresco Labs (CRLBF) has a gross margin of 49.5%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. On trailing twelve month revenue of $655.8M, this translates to an estimated gross profit of approximately $324.6M. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A moderate gross margin like Cresco Labs's suggests the company has pricing power and operational efficiency relative to peers.

Cresco Labs (CRLBF) has traded between a 52-week low of $0.59 and a 52-week high of $2.30, with the current price of $0.61 sitting approximately -73% from the annual high. This range represents a spread of $1.71 (291% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.

Cresco Labs (CRLBF) holds $94.3M in cash and equivalents on its balance sheet, set against $431.2M in total debt. This gives the company a net debt position of $336.8M. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.

Cresco Labs (CRLBF) currently has 355.0M shares outstanding, which when multiplied by the current stock price of $0.61 gives the company its market capitalization of $223.7M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.